Skip to content

Insider · CIK 0001877585

Nicki Vasquez

officer

Files at STRO (SUTRO BIOPHARMA, INC.). First filing Jan 31, 2024, latest Jan 31, 2024.

In brief

Nicki Vasquez files SEC Form 4 as officer at STRO (SUTRO BIOPHARMA, INC.). Since Jan 31, 2024, Nicki Vasquez has reported 0 open-market buys worth $0 and 1 open-market sell worth $61k, the latest filed on Jan 31, 2024.

A track record needs three past buys with six months of prices behind them; Nicki Vasquez has 0, so none is measured yet.

The newest scored trade: sold $61k of STRO on Jan 29, 2024, filed Jan 31, 2024, scored 0 (weak), under a 10b5-1 plan.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $61k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

STRO: SUTRO BIOPHARMA, INC.

STROOct 13, 2026 · close 11.01

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
0Weak
STROsell10b5-1
SUTRO BIOPHARMA, INC.
$61k
12,185 shares
-49%+141% from low-32% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jan 29, 2024 STRO
SUTRO BIOPHARMA, INC.
12,185
0.02% of outstanding
$61kJan 29, 2024none

Transactions

Every row this insider has filed, 4 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 29, 2024STRO
SUTRO BIOPHARMA, INC.
SOpen-market sale
Common Stock10b5-1
-12,185$5.00$61k12,803Jan 31, 2024
Jan 29, 2024STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Common Stock10b5-1
+2,500$0.00$015,303Jan 31, 2024
Jan 29, 2024STRO
SUTRO BIOPHARMA, INC.
FTax withholding
Common Stock10b5-1
-1,024$4.99$5,11014,279Jan 31, 2024
Jan 29, 2024STRO
SUTRO BIOPHARMA, INC.
MOption exercise
Restricted Stock Unit (RSU)derivative10b5-1
-2,500$0.00$00Jan 31, 2024

Questions about Nicki Vasquez

Answered from the filings on this page, as of the latest one.

Is Nicki Vasquez buying or selling?

Not in the last 12 months. Nicki Vasquez's latest open-market trade on SEC Form 4 was sold $61k of STRO on Jan 29, 2024.

How did Nicki Vasquez's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Nicki Vasquez has 0.

Where does Nicki Vasquez file Form 4?

Nicki Vasquez has filed Form 4 at STRO (SUTRO BIOPHARMA, INC.) as CHIEF PORT. STRAT & ALNCE OFCR. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Nicki Vasquez: insider trades and track record | InsiderTell